University of Minnesota-developed drug for rigid muscles moves ahead in clinical trials
(University of Minnesota Academic Health Center) A new formulation for a University of Minnesota-developed drug targeted at rare disorders is under development, with the potential to help a small number of Americans each year. The new formulation of the drug baclofen is designed to prevent serious complications that can occur when drug delivery is interrupted.
Source: EurekAlert! - Medicine and Health - Category: Global & Universal Source Type: news
More News: Academia | Baclofen | Clinical Trials | Health | International Medicine & Public Health | University of Minnesota